NCT03435952 2026-04-16Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTM.D. Anderson Cancer CenterPhase 1 Active not recruiting18 enrolled
NCT03091192 2026-04-14Savolitinib vs. Sunitinib in MET-driven PRCC.AstraZenecaPhase 3 Active not recruiting60 enrolled 15 charts
NCT03420963 2026-03-20Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled